CY1110576T1 - Χρηση της ακετυλ l-καρνιτινης για τη θεραπεια του ινομυαλγικου συνδρομου - Google Patents

Χρηση της ακετυλ l-καρνιτινης για τη θεραπεια του ινομυαλγικου συνδρομου

Info

Publication number
CY1110576T1
CY1110576T1 CY20091100383T CY091100383T CY1110576T1 CY 1110576 T1 CY1110576 T1 CY 1110576T1 CY 20091100383 T CY20091100383 T CY 20091100383T CY 091100383 T CY091100383 T CY 091100383T CY 1110576 T1 CY1110576 T1 CY 1110576T1
Authority
CY
Cyprus
Prior art keywords
acetyl
treatment
karnitine
fibm
carnitine
Prior art date
Application number
CY20091100383T
Other languages
Greek (el)
English (en)
Inventor
Aleardo Koverech
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of CY1110576T1 publication Critical patent/CY1110576T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
CY20091100383T 2004-12-13 2009-03-31 Χρηση της ακετυλ l-καρνιτινης για τη θεραπεια του ινομυαλγικου συνδρομου CY1110576T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000606A ITRM20040606A1 (it) 2004-12-13 2004-12-13 Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica.
EP05807584A EP1824472B1 (en) 2004-12-13 2005-11-10 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome

Publications (1)

Publication Number Publication Date
CY1110576T1 true CY1110576T1 (el) 2015-04-29

Family

ID=35708966

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100383T CY1110576T1 (el) 2004-12-13 2009-03-31 Χρηση της ακετυλ l-καρνιτινης για τη θεραπεια του ινομυαλγικου συνδρομου

Country Status (16)

Country Link
US (1) US8013016B2 (enExample)
EP (1) EP1824472B1 (enExample)
JP (1) JP5057990B2 (enExample)
KR (1) KR101240182B1 (enExample)
AT (1) ATE419847T1 (enExample)
CA (1) CA2585560C (enExample)
CY (1) CY1110576T1 (enExample)
DE (1) DE602005012317D1 (enExample)
DK (1) DK1824472T3 (enExample)
ES (1) ES2320788T3 (enExample)
IT (1) ITRM20040606A1 (enExample)
MX (1) MX2007006954A (enExample)
PL (1) PL1824472T3 (enExample)
PT (1) PT1824472E (enExample)
SI (1) SI1824472T1 (enExample)
WO (1) WO2006063639A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2840363A1 (en) * 2011-06-24 2012-12-27 K-Pax Pharmaceuticals, Inc. Compositions comprising a central nervous system stimulant and select micronutrients useful in the treatment of chronic fatigue
ES2962933T3 (es) 2020-12-14 2024-03-21 Ims Gear Se & Co Kgaa Procedimiento para la corrección de una señal de medición dependiente del tiempo de una unidad de motor-engranaje, así como procedimiento para detectar desgaste y/o un deterioro de la misma mediante este procedimiento de corrección

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US5935949A (en) * 1998-03-20 1999-08-10 Trustees Of Dartmouth College Use of androgen therapy in fibromyalgia and chronic fatigue syndrome
US6803387B1 (en) 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
ITRM20010293A1 (it) 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
KR101027570B1 (ko) * 2002-05-03 2011-04-06 이스라엘 인스티튜트 포 바이올로지컬 리서치 중추 및 말초 신경계 장애의 치료를 위한 방법 및 조성물, 및 그에 유용한 신규 화합물

Also Published As

Publication number Publication date
EP1824472B1 (en) 2009-01-07
ITRM20040606A1 (it) 2005-03-13
JP5057990B2 (ja) 2012-10-24
ATE419847T1 (de) 2009-01-15
US20090076146A1 (en) 2009-03-19
KR101240182B1 (ko) 2013-03-07
KR20070091317A (ko) 2007-09-10
CA2585560C (en) 2013-01-08
PL1824472T3 (pl) 2009-05-29
SI1824472T1 (sl) 2009-04-30
ES2320788T3 (es) 2009-05-28
MX2007006954A (es) 2007-08-02
EP1824472A1 (en) 2007-08-29
CA2585560A1 (en) 2006-06-22
WO2006063639A1 (en) 2006-06-22
DK1824472T3 (da) 2009-03-30
JP2008534433A (ja) 2008-08-28
PT1824472E (pt) 2009-03-31
DE602005012317D1 (de) 2009-02-26
US8013016B2 (en) 2011-09-06

Similar Documents

Publication Publication Date Title
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
CY1107302T1 (el) Χρηση ρεσβερατρολης για την παρασκευη ενος φαρμακου που ειναι χρησιμο για τη θεραπεια λοιμωξεων απο τον ιο της γριπης
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
JP2005511619A5 (enExample)
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
CY1111273T1 (el) Συνδυασμενη χρηση της l-καρνιτινης, ακετυλο l-καρνιτινης και προπιονυλο l-καρνιτινης για τη θεραπεια της ολιγοασθενοτερατοσπερμιας
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
CY1110576T1 (el) Χρηση της ακετυλ l-καρνιτινης για τη θεραπεια του ινομυαλγικου συνδρομου
CY1111430T1 (el) Χρηση της αγομελατινης για τη ληψη φαρμακων που προοριζονται για τη θεραπεια του συνδρομου smith magenis
AR052152A1 (es) Producto farmaceutico para el tratamiento preventivo y terapeutico de trastornos del sueno
JP2005505605A5 (enExample)
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
CY1107037T1 (el) Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου
ITRM20020492A0 (it) Uso della propionil l-carnitina per la preparazione di un medicamentoper il trattamento del glaucoma.
DE60300683D1 (de) Prucaloprid-n-oxid
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
PT1937245E (pt) Composto útil para a prevenção e o tratamento de hipertrofia ventricular esquerda em pacientes dialisados
UA132547U (uk) Лікарський засіб знеболювальної та спазмолітичної дії
ATE326974T1 (de) Blockierung der anlagerung von keimen bei vögeln
ITRM20020181A1 (it) Medicamento utile per il trattamento della fatica in pazienti affettida sclerosi multipla.
AR025498A1 (es) Una nueva asociacion farmaceutica que presenta un efecto analgesico
WO2006084793A3 (de) Filmtabletten enthaltend ibuprofen-lysinat